Access to benznidazole for Chagas disease in the United States—Cautious optimism?

Open Access

Viewpoints are opinion pieces grounded in evidence on topics of broad interest to the journal's readership.

Jonathan D. Alpern ,

* E-mail: alper054@umn.edu

Affiliation Division of Infectious Disease & International Medicine, Department of Internal Medicine, University of Minnesota, Minneapolis, Minnesota, United States of America

http://orcid.org/0000-0001-8514-8693

⨯
Rogelio Lopez-Velez,

Affiliation National Referral Unit for Tropical Diseases, Infectious Diseases Department, Ramón y Cajal Hospital University Hospital, Madrid, Spain
⨯
William M. Stauffer

Affiliation Division of Infectious Disease & International Medicine, Department of Internal Medicine, University of Minnesota, Minneapolis, Minnesota, United States of America
⨯

Reader Comments (0)

Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Chagas disease
Is the Subject Area "Chagas disease" applicable to this article?

Thanks for your feedback.
Intravenous injections
Is the Subject Area "Intravenous injections" applicable to this article?

Thanks for your feedback.
Malaria
Is the Subject Area "Malaria" applicable to this article?

Thanks for your feedback.
Neglected tropical diseases
Is the Subject Area "Neglected tropical diseases" applicable to this article?

Thanks for your feedback.
Antiparasitic therapy
Is the Subject Area "Antiparasitic therapy" applicable to this article?

Thanks for your feedback.
Trypanosoma cruzi
Is the Subject Area "Trypanosoma cruzi" applicable to this article?

Thanks for your feedback.
Drug prices
Is the Subject Area "Drug prices" applicable to this article?

Thanks for your feedback.